‘BOOST-3’ Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury

Treatment based on brain tissue oxygen levels might help patients have better recoveries. A new clinical coordinating center will help researchers find out.

7:00 AM

Author | Kylie Urban

An estimated 2.5 million Americans sustain a traumatic brain injury, or TBI, each year, according to the Centers for Disease Control and Prevention. Severe TBI contributes to 30 percent of all injury-related deaths, and many who survive are left permanently disabled.

"Of the nearly 300,000 hospital admissions annually for TBI, about 40 percent are classified as severe," says William Barsan, M.D., a professor of emergency medicine at Michigan Medicine.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

"Unfortunately, less than 20 percent of patients with a severe TBI make a good recovery — and many are left with lifelong disabilities and medical needs."

Barsan is one of the principal investigators of an ongoing emergency department clinical trial, Brain Oxygen Optimization in Severe TBI, Phase 3 (BOOST-3), which aims to improve outcomes for severe TBI patients.

In addition to Barsan, primary investigators for the BOOST-3 trial are Ramon Diaz-Arrastia, M.D., Ph.D., director of the Traumatic Brain Injury Clinical Research Center in the Perelman School of Medicine at the University of Pennsylvania; Lori Shutter, M.D., professor of critical care medicine, neurology and neurosurgery at the University of Pittsburgh and medical director of neurointensive care units at the University of Pittsburgh Medical Center; and Sharon Yeatts, Ph.D., associate professor of biostatistics at the Medical University of South Carolina.

Severe TBI patients in the intensive care unit have been managed by monitoring intracranial pressure and treating the elevated pressure to prevent secondary injury, Barsan notes.

Our main goal is to improve long-term outcome and improve quality of life after severe TBI through the results of the BOOST-3 trial.
William Barsan, M.D.

But recent clinical trial data have shown that this approach may not be enough.

"New trials are showing that monitoring the partial pressure of oxygen in brain tissue allows for more timely interventions," Barsan says. "Because of this, many physicians have started measuring brain oxygen in these patients as part of standard practice. It is unknown if this strategy, which requires an additional procedure, is better, worse or the same as the traditional approach."

That's why Barsan, Diaz-Arrastia, Shutter and Yeatts designed the BOOST-3 trial.

This $32 million trial will be conducted in the National Institutes of Health-funded Strategies to Innovate Emergency Care Clinical Trials Network (SIREN). Michigan Medicine is the clinical coordinating center for the network.

Building on prior research

Diaz-Arrastia and Shutter conducted the trial's second phase, BOOST-2, which was published in 2017. That trial hypothesized that treating patients based on measurements of both intracranial pressure and brain oxygen levels would reduce the duration and severity of periods in which brain tissue oxygen levels were low in patients with TBI compared with treatment of intracranial pressure alone.

MORE FROM THE LAB: Subscribe to our weekly newsletter

The team explained that low levels of brain tissue oxygen can cause further loss of brain cells or prevent their recovery. Knowing about both pressure and oxygen in the brain may provide critical care doctors the clues they need to precisely adjust medications and breathing machine settings for patients.

"We found that brain hypoxia burden was reduced by 74 percent in the patients monitored and treated based on partial pressure of oxygen in brain tissue and intracranial pressure monitoring compared to intracranial pressure monitoring alone," Shutter says. "We're now building upon the data we collected in the BOOST-2 trial and moving onto this third phase, where we will expand our hypothesis."

That new hypothesis: Treating TBI based on partial pressure of oxygen in the brain tissue and intracranial pressure monitoring will improve neurological outcomes six months after the injury compared with treatment based on intracranial pressure monitoring alone.

"It's important to consider the long-term survival and health of patients with TBI," Shutter says. "This phase of the trial will show whether we can improve long-term outcome with this treatment strategy."

A coordinated effort

BOOST-3 will begin in 2018 at 45 SIREN clinical sites across the United States and will continue for five years.

It plans to enroll 1,094 participants with severe TBI. Subjects will be randomized within six hours of arriving at an enrolling hospital, but no longer than 12 hours from injury.

All patients will have brain tissue oxygen monitors and intracranial pressure monitors placed within six hours of arrival at the hospital. Patients will then be randomized to treatment based on intracranial pressure alone or treatment based on both intracranial pressure and brain tissue oxygen levels for the first five days after admission, with all other care being standard.

SEE ALSO: Focusing on 'Golden Hours' of Care to Improve Traumatic Brain Injury Outcomes

Subjects will be followed for six months, and investigators will compare the functional outcomes and neurological function of the two groups.

SIREN seeks to improve the outcomes of patients with neurologic, cardiac, respiratory, hematologic and trauma emergencies by identifying effective treatments administered in the earliest stages of critical care and is supported by the National Institute for Neurological Disorders and Stroke (NINDS) and the National Heart, Lung and Blood Institute (NHLBI). Beyond Michigan Medicine, the network includes a data coordinating center at the Medical University of South Carolina and 11 award hubs with primary investigators at each.    

"Improving the recovery of patients with severe brain injury is an important priority at the NIH," says Jeremy Brown, M.D., the NINDS medical officer who works with the SIREN team. "The results of this trial will provide important information which doctors and nurses around the country will then use to benefit the patients in their care."

Excitement for the collaborative approach on the study is shared across institutions.

"The SIREN data coordinating center at the Medical University of South Carolina could not be more excited about helping to lead this effort to improve the care of severe TBI patients," Yeatts says. "My team at MUSC has been collaborating with TBI experts across the country on various trials, and we now have the opportunity to help to inform health care providers of best treatment approaches so patients all over the country will have better outcomes.

"Regardless of the results, this study will have a dramatic impact, and we are proud to be a part of it."

Barsan, Diaz-Arrastia, Shutter and Yeatts hope this phase of the trial will build upon the findings from BOOST-2.

"We truly hope this clinical trial will provide emergency, neurosurgery and critical care physicians with improved treatment protocols for severe TBI going forward," Barsan says. "Our main goal is to improve long-term outcome and improved quality of life after severe TBI through the results of the BOOST-3 trial."


More Articles About: Industry DX Critical Care Trauma Clinical Trials Emergency & Trauma Care
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories older woman walking with older man look from behind in their home
Health Lab
For traumatic brain injury caregivers, a mobile health intervention that may improve quality of life
It is important for caregivers to take care of their personal needs and mental health to efficiently give care to others. University of Michigan Health researchers are using a new app to remind caregivers to check in with their own physical and mental wellbeing.
Little girl sits on a bike that looks like a car and rides around the fake town, built to teach her about cross the street safely.
Department News
U-M’s Pop-Up Safety Town Teaches Injury Prevention and Helps Keep Kids Out of the ER
Pop-Up Safety Town, a community outreach initiative by the University of Michigan’s Department of Emergency Medicine in partnership with the U-M Concussion Center, brings free, hands-on injury prevention education to underserved communities across Michigan. Designed for children ages three to six, the program teaches vital safety skills, like helmet use, medication safety, and pedestrian awareness, through interactive events and classroom kits. By engaging families directly in schools and community spaces, and expanding through partnerships and national scaling efforts, the initiative aims to reduce preventable childhood injuries and keep kids out of the emergency room.
Group photos of the Scholars
Department News
Launching the Next Generation of Emergency Medicine Researchers
The K12 Neuro-EM Scholars Program, launched in 2024 at the University of Michigan’s Weil Institute and funded by the NIH’s National Institute of Neurological Disorders and Stroke, is the first national initiative designed to train early-career emergency medicine (EM) faculty in neurological research. With dedicated funding, mentorship, and a focus on high-impact research, the program supports scholars as they pursue independent research careers focused on critical, time-sensitive neurological emergencies. In its inaugural year, four scholars were selected, with additional support provided through a Pipeline Program for emerging researchers. The initiative is quickly building a nationwide community of EM physician-scientists committed to advancing care for neurological emergencies.
person looking at test close up
Health Lab
Revolutionizing head injury care
A simple blood test is changing how emergency medicine operates.
Diane Gregory, a, Emergency Department Laboratory Technician, uses a small devices to test for TBI biomarkers.
Department News
Revolutionizing Head Injury Care
When Francine Bomar fell and hit her head, she feared a long ER wait and a CT scan—but instead, she became one of the first patients at Michigan Medicine to benefit from a groundbreaking new blood test for traumatic brain injury (TBI). Introduced in December 2024 and developed by Dr. Fred Korley and his team, the test rapidly detects two brain-specific proteins, providing results in 15 minutes and reducing the need for CT scans. In just a few months, it has already helped avoid 95 unnecessary CTs. With strong clinical support and funding from the Department of Defense, researchers are now developing a handheld version, aiming to make personalized, efficient brain injury care accessible everywhere.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.